Current Liabilities
Other accrued liabilities
Biogen Other accrued liabilities decreased by 9.1% to $2.55B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.6%, from $2.53B to $2.55B. Over 5 years (FY 2020 to FY 2025), Other accrued liabilities shows a downward trend with a -2.3% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ3 2025
Last reportedQ1 2026
How to read this metric
Significant changes should be analyzed to determine if they represent one-time adjustments or shifts in operational expense timing.
Detailed definition
This represents miscellaneous short-term obligations that do not fall into standard categories like accounts payable or...
Peer comparison
Standard residual category; peers report this as other current liabilities.
Metric ID:
current_liabilities_other_liabilities_currentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.74B | $2.55B | $2.54B | $2.23B | $3.30B | $3.31B | $2.52B | $2.29B | $2.48B | $3.84B | $2.62B | $2.35B | $2.47B | $2.76B | $2.81B | $2.53B | $2.66B | $2.77B | $2.80B | $2.55B |
| QoQ Change | — | -6.9% | -0.6% | -12.0% | +47.8% | +0.2% | -23.7% | -9.2% | +8.4% | +54.7% | -31.6% | -10.3% | +5.0% | +11.4% | +1.9% | -9.9% | +5.1% | +4.3% | +1.0% | -9.1% |
| YoY Change | — | — | — | — | +20.3% | +29.6% | -0.5% | +2.6% | -24.8% | +16.1% | +4.1% | +2.9% | -0.4% | -28.2% | +7.0% | +7.5% | +7.6% | +0.7% | -0.2% | +0.6% |
Range$2.23B – $3.84B
CAGR-1.5%
Avg YoY Growth+2.8%
Median YoY Growth+2.7%
Other accrued liabilities at Other Companies
Frequently Asked Questions
- What is Biogen's other accrued liabilities?
- Biogen (BIIB) reported other accrued liabilities of $2.55B in Q1 2026.
- How has Biogen's other accrued liabilities changed year-over-year?
- Biogen's other accrued liabilities increased by 0.6% year-over-year, from $2.53B to $2.55B.
- What is the long-term trend for Biogen's other accrued liabilities?
- Over 5 years (2020 to 2025), Biogen's other accrued liabilities has grown at a -2.3% compound annual growth rate (CAGR), from $3.15B to $2.80B.
- What does other accrued liabilities mean?
- Miscellaneous short-term debts that do not fit into standard categories like accounts payable.